Drug-resistant tuberculosis in high-risk groups, Zimbabwe. To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.
GlobalResearch at UCSF presents the broad scope of health research that is being conducted by UCSF researchers worldwide